$8.40
2.44%
Nasdaq, Oct 07, 04:00 pm EDT. Closed.
ISIN
US41015N1063
Symbol
NVNO

Hancock Jaffe Laboratories, Inc. Stock price

$8.40
-3.04 26.57% 1M
-1.93 18.68% 6M
-2.83 25.19% YTD
-25.17 74.98% 1Y
-192.15 95.81% 3Y
-331.80 97.53% 5Y
-4,576.60 99.82% 10Y
-4,576.60 99.82% 20Y
Nasdaq, Closing price Wed, Oct 07 2026
+0.20 2.44%

Is Hancock Jaffe Laboratories, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,113 stocks worldwide.

Key metrics

Basic
Market capitalization
$5.8m
Enterprise Value
$-15.7m
Net debt
positive
Cash
$21.5m
Shares outstanding
670.0k
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
1.1 | 0.9
P/B
0.3
Financial Health
Equity Ratio
91.8%
Return on Equity
-
ROCE
-80.7%
ROIC
-
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$2.2m | -
SBC as % of FCF
-
SBC Growth 1Y
-46.8%
Share Count Growth 1Y
21.8%
Shareholder Yield
-21.8%
Financials
Revenue | estimate
$0.0 | $0.0
EBITDA
-
EBIT
$-16.8m
Net Income
$-15.7m
Free Cash Flow | ex SBC
$-14.6m | $-16.8m
Growth
Revenue | estimate
- | -
EBITDA
-
EBIT
32.6%
Net Income
31.9%
Free Cash Flow
14.7%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$-23.4
FCF per Share
$-21.8
Short interest
1.4%
Employees
33
Rev per Employee
-

Hancock Jaffe Laboratories, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Hancock Jaffe Laboratories, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Hancock Jaffe Laboratories, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Hancock Jaffe Laboratories, Inc.

Jun '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 8.03 8.03
38% 38%
-
- Research and Development Expense 8.72 8.72
26% 26%
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -17 -17
33% 33%
-
Net Profit -16 -16
32% 32%
-

In millions USD.

Don't miss a Thing! We will send you all news about Hancock Jaffe Laboratories, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Hancock Jaffe Laboratories, Inc. Stock News

Neutral
Accesswire
●
6 days ago
Leading venous interventionalist Karen B. Garby, MD, DABVLM, RPhS, to present the enVVe® System, a minimally invasive replacement venous valve currently being evaluated in a U.S. pivotal study An estimated 3 million patients in the U.S. suffer from severe, deep venous insufficiency with no effective treatment IRVINE, CA / ACCESS Newswire / October 2, 2026 / enVVeno Medical Corporation (Nasdaq:N...
Neutral
Accesswire
●
27 days ago
Access the video webcast here IRVINE, CA / ACCESS Newswire / September 11, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that its pre-recorded presentation from the H.C. Wainwright 28th Annual Global Investment Conference is now available for on-demand viewing here.
Neutral
Accesswire
●
about one month ago
Video Webcast Now Available Here IRVINE, CA / ACCESS Newswire / August 27, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company") today announced that Robert Berman, Chief Executive Officer of enVVeno Medical, participated in the Virtual Investor "Why Now" on-demand conference. For the event, Mr.
More Hancock Jaffe Laboratories, Inc. News

Company Profile

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.

Head office United States
CEO Mr. Berman
Employees 33
Founded 1999
Website envveno.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today